Insiders · Profile

Day Lucy

Chief Financial Officer at AN2 Therapeutics. Filing since 3 Jan 2025. CIK 0001914510

Company

Date

Role

Action

Amount

Of holding

6 Jan 2026

Chief Financial Officer

Sold at will

5,512

$5.58K

6.8%

5 Jan 2026

Chief Financial Officer

Sold at will

3,295

$3.30K

3.9%

3 Jan 2025

Chief Financial Officer

Sold at will

2,957

$3.97K

8.3%

3 decisions on file.